Mr Mukhtar M Nalado, LADC | |
495 Congress Ave, New Haven, CT 06519-1312 | |
(203) 781-4600 | |
(203) 781-4624 |
Full Name | Mr Mukhtar M Nalado |
---|---|
Gender | Male |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 495 Congress Ave, New Haven, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013447523 | NPI | - | NPPES |
008022622 | Medicaid | CT | |
004082260 | Medicaid | CT | |
008073258 | Medicaid | CT | |
008001325 | Medicaid | CT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | 001238 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Mukhtar M Nalado, LADC 1 Long Wharf Dr Ste 321, New Haven, CT 06511-5991 Ph: (203) 781-4600 | Mr Mukhtar M Nalado, LADC 495 Congress Ave, New Haven, CT 06519-1312 Ph: (203) 781-4600 |
News Archive
Part of heading back to school is actually getting your kids back to school safely. According to the Centers for Disease Control, on average, there is one pedestrian death every two hours and a pedestrian injury every eight minutes in the United States. Vehicles and kids can be a very scary combination whether the child is walking, biking, riding or driving.
Kaiser Health News staff writer Phil Galewitz, in collaboration with McClatchy, reports: "Like half the states, South Carolina chose not to expand Medicaid under the federal health law next year, citing the program's high costs and inefficiency. Yet, state officials still forecast a 16 percent enrollment jump by the end of June, 2015, triple that of a typical year and even higher than the 12 percent average increase expected in states that are expanding eligibility.
Researchers at the University of Toronto have uncovered new insights on the genetic causes of Amyotrophic Lateral Sclerosis (ALS), which is also known as Lou Gehrig's disease. These findings could uncover a new way to detect a genetic predisposition to ALS before the disease strikes.
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago.
› Verified 1 days ago
Rachel B Kopanski, BA Counselor Medicare: Not Enrolled in Medicare Practice Location: 400 Columbus Ave, New Haven, CT 06519 Phone: 203-503-3250 Fax: 203-503-3254 | |
Joann Rotar, MS, NCC, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 869 Whalley Ave, New Haven, CT 06515 Phone: 203-491-1652 | |
Mr. Mark C Vanacore, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 871 State St, New Haven, CT 06511 Phone: 203-776-9900 Fax: 203-387-8522 | |
Dr. Rita W. Mccleary, PSY.D. Counselor Medicare: Medicare Enrolled Practice Location: 258 Bradley St, New Haven, CT 06510 Phone: 203-777-4045 | |
Mr. Pedro Delgado, BS. Counselor Medicare: Not Enrolled in Medicare Practice Location: 317 Lexington Ave, 2nd Floor, New Haven, CT 06513 Phone: 203-464-6913 | |
Cluny Gombar, LPC Counselor Medicare: Medicare Enrolled Practice Location: 400 Columbus Ave, New Haven, CT 06519 Phone: 203-503-3055 Fax: 203-503-3066 |